3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lichen Planus
1
Leukokeratosis, Hereditary Mucosal
1
Leukemia, Myeloid, Acute
1
Fanconi Anemia
1
Erythroplasia
1
COVID-19
1
Interventions
Cyclophosphamide
22
fludarabine phosphate
17
Cyclosporine
15
Peripheral Blood Stem Cell Transplantation
14
Methotrexate
14
Filgrastim
14
Whole-Body Irradiation
11
Mycophenolic Acid
11
Busulfan
11
Antilymphocyte Serum
11
Radiotherapy
8
Melphalan
8
Exercise
8
Dexamethasone
8
Cytarabine
8
Asparaginase
8
venetoclax
7
blinatumomab
7
Vincristine
7
Etoposide
7
Daunorubicin
7
fludarabine
6
Methylprednisolone
6
Mercaptopurine
6
Granulocyte Colony-Stimulating Factor
6
Therapeutics
5
Psychiatric Rehabilitation
5
Prednisone
4
Immunotherapy, Adoptive
4
Cord Blood Stem Cell Transplantation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Molecular Diagnostic Techniques
×
Clear all
NCT02435550
2019-12-20
iCare for Cancer Patients
University of Florida
Phase NA
Terminated
136 enrolled